Natick, MA - The US FDA has granted marketing clearance for the FilterWire EZ embolic-protection system for use in carotid stenting, the manufacturer, Boston Scientific, announced yesterday. The ...

Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...

SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...

Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...

Please provide your email address to receive an email when new articles are posted on . How many randomized clinical trials of parachutes vs. no parachutes are there? The answer, of course, is none.

DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Embolic protection systems Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. This report provides key ...

A redesigned embolic protection device failed to protect transcatheter aortic valve replacement (TAVR) patients against stroke, the REFLECT II study showed. Efficacy outcomes were no better ...